Base editor treats progeria in mice.

A single dose of an adenine base editor shows promise in treating the ageing-related disease Hutchinson–Gilford progeria syndrome. It corrected the LMNA mutation underlying the disease in patient-derived cells and improved cardiovascular health and lifespan in mice. Single dose of adenine base editor shows promise in treating ageing-related syndrome.